Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Toward a Biogenerics Market: The Regulatory Conundrum

Published by: Decision Resources

Published: Dec. 20, 2006 - 31 Pages

Price reduced due to age.

Table of Contents



Executive Summary

Strategic Considerations

Stakeholder Implications




Introduction

Biologics Market: Background and Status

Origins and Progress of the Industry

Key Biologic Brands




Existing Regulatory Pathways for Biologics

U.S. Biologic Regulation: An Evolving and Complicated History

European Biologic Regulation: the EMEA’s Centralized Procedure




Stumbling Blocks for Biogenerics

Biologics: Is the Process the Product?

For Some Products, U.S. Generics Manufacturers Point to 505(b)(2)

For BLA-Regulated Products, Nowhere to Start

Biogenerics Finally Crash the Party

The EMEA Gives the Green Light to the First Biogenerics

Omnitrope Fights Its Way to the U.S. Market

Proactive Legislation in the United States and Europe

United States—At Least a Beginning

Implications of Omnitrope’s Approval

Access to Life-Saving Medicine Act

Europe—A More Concrete Approach




Remaining Challenges




A Look at Select Commercial Contenders

Biologics Companies

Biogenerics Companies

Sandoz

Teva Pharmaceuticals

Pliva (Barr Pharmaceuticals)

Dr. Reddy’s Labs

Wockhardt

BiogeneriX (Ratiopharm)

Stada Biogenerics

BioPartners

Cangene

Dragon Pharmaceuticals

GeneMedix

Momenta Pharmaceuticals

Phage Biotechnology

Prolong Pharmaceuticals

ScinoPharm Biotech

Shantha Biotech




Tables

1. Patent and Exclusivity Expiries of Key Biologics

2. EMEA’s Adopted Biosimilar Guidelines as of November 2006

3. EMEA’s Working Concept Papers for Biogenerics Approvals as of November 2006

4. Key Challenges for Biogenerics Manufacturers




Figures

1. U.S. Biotech Industry Sales Growth, 1994-2004

2. Timeline of Biogenerics Commercialization Milestones

3. Top Biotech Companies: Annual Company-Reported Net Sates Revenues, 2000-2005

4. Business Strategies for Tapping the Biologics Market with Biogenerics

Abstract

Introduction

The sales that biologic agents command and the costs that they impose for payers combine to generate intense interest in the development of generic biologic agents, or biogenerics. However, the biogenerics market has been very slow to establish itself. The key reason is the lack of a defined regulatory framework and uncertainty—on the part of manufacturers and regulators alike—regarding what biogenerics will look like and how they will reach the market.

Get the Answers You Need to Shape Your Strategy

In the spring of 2006, two companies made history by producing the fi rst two approved biogenerics in the European Union. Which two companies were they, and what products were approved? What steps has the European Medicines Agency (EMEA) taken to clarify the path to approval?

The biologics that bring in the most sales will be the natural focus of biogeneric development. Which branded biologics are the most popular targets? In late September 2006, Representative Henry Waxman introduced the Access to Life-Saving Medicine Act, which would amend section 351 of the Public Health Service Act. How could this bill foster the development of biogeneric products in the United States? What other actions are interested parties taking?

Several generic drug manufacturers have entered or are hoping to enter the biogenerics market. Which companies are they and which biological products are they targeting? What business models are they using?

Scope
  • The biologics market: origins and progress.
  • The regulatory pathway for biologics: United States and Europe.
  • The biogenerics market: origins and progress.
  • Current and potential regulatory pathways for biogenerics: United States and Europe.
  • Select company profi les: biopharmaceutical companies and biogenerics companies.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options
See related reports or call the number above for help from a research specialist.


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008